Effect of dipeptidyl peptidase-4 inhibitors inhibitor on cognitive dysfunction in diabetes: A protocol for systematic review and meta analysis

INTRODUCTION: There is a risk of cognitive impairment in diabetic patients. Some studies have shown that dipeptidyl peptidase-4 inhibitors (DPP-4) inhibitors can play a protective role in controlling blood glucose and blocking the DPP-4 to attach antibody glucagon-like peptide -1 degradation and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiyu, Wang, Xian, Deng, Huan, Xia, Yuguo, Yang, Xiaomei, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402785/
https://www.ncbi.nlm.nih.gov/pubmed/32756077
http://dx.doi.org/10.1097/MD.0000000000020707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402785/
https://www.ncbi.nlm.nih.gov/pubmed/32756077
http://dx.doi.org/10.1097/MD.0000000000020707

Ejemplares similares